GR3026584T3 - Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration. - Google Patents

Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration.

Info

Publication number
GR3026584T3
GR3026584T3 GR980400773T GR980400773T GR3026584T3 GR 3026584 T3 GR3026584 T3 GR 3026584T3 GR 980400773 T GR980400773 T GR 980400773T GR 980400773 T GR980400773 T GR 980400773T GR 3026584 T3 GR3026584 T3 GR 3026584T3
Authority
GR
Greece
Prior art keywords
pct
rectal administration
alkylsulphonamides
agonists
pharmaceutical compositions
Prior art date
Application number
GR980400773T
Other languages
Greek (el)
English (en)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Glaxo Wellcome Lab
Glaxo Wellcome Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa, Glaxo Wellcome Lab, Glaxo Wellcome Lab Sa filed Critical Glaxo Lab Sa
Publication of GR3026584T3 publication Critical patent/GR3026584T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
GR980400773T 1992-05-07 1998-04-10 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration. GR3026584T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (1)

Publication Number Publication Date
GR3026584T3 true GR3026584T3 (en) 1998-07-31

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400773T GR3026584T3 (en) 1992-05-07 1998-04-10 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration.

Country Status (33)

Country Link
US (1) US5705506A (OSRAM)
EP (1) EP0639072B1 (OSRAM)
JP (1) JPH07506570A (OSRAM)
KR (1) KR100253111B1 (OSRAM)
AT (1) ATE163850T1 (OSRAM)
AU (1) AU670083B2 (OSRAM)
BE (1) BE1007024A5 (OSRAM)
BG (1) BG62120B1 (OSRAM)
BR (1) BR1100108A (OSRAM)
CA (1) CA2135179C (OSRAM)
CH (1) CH685920A5 (OSRAM)
CY (1) CY2039B1 (OSRAM)
CZ (1) CZ283512B6 (OSRAM)
DE (1) DE69317418T2 (OSRAM)
ES (1) ES2113533T3 (OSRAM)
FR (1) FR2690847B1 (OSRAM)
GB (2) GB9209882D0 (OSRAM)
GR (1) GR3026584T3 (OSRAM)
HK (1) HK95697A (OSRAM)
HU (2) HU227338B1 (OSRAM)
IE (1) IE75203B1 (OSRAM)
IL (1) IL105468A (OSRAM)
IT (1) IT1261471B (OSRAM)
NO (1) NO306700B1 (OSRAM)
NZ (1) NZ252132A (OSRAM)
OA (1) OA10109A (OSRAM)
RO (1) RO112993B1 (OSRAM)
RU (1) RU2118527C1 (OSRAM)
SG (1) SG46649A1 (OSRAM)
TW (1) TW231970B (OSRAM)
UA (1) UA37206C2 (OSRAM)
WO (1) WO1993021916A1 (OSRAM)
ZA (1) ZA933178B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT2198858E (pt) * 1998-03-26 2011-09-01 Astellas Pharma Inc Composição farmacêutica de libertação constante que contém um macrólido como o tacrolimus
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
CA2749273C (en) 2008-01-09 2018-09-04 Charleston Laboratories, Inc. Pharmaceutical oral dosage form comprising a triptan and an antiemetic
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
CN103402514B (zh) 2010-10-15 2016-01-13 康特拉医药公司 用于治疗运动障碍的血清素受体激动剂组合物
HUE037732T2 (hu) 2012-04-18 2018-09-28 Contera Pharma Aps A mozgászavarok fejlett kezelésére alkalmas, szájon át szedhetõ gyógyszerészeti készítmény
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CA3030089C (en) 2016-07-11 2024-04-23 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU550010B2 (en) * 1980-08-12 1986-02-27 Glaxo Group Limited 5-tryptaminoacetamides, carbamates and ureas
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GR79215B (OSRAM) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4785016A (en) * 1984-12-04 1988-11-15 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
FI92397C (fi) * 1987-08-13 1994-11-10 Glaxo Group Ltd Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer

Also Published As

Publication number Publication date
GB9209882D0 (en) 1992-06-24
ITRM930286A0 (it) 1993-05-06
DE69317418D1 (de) 1998-04-16
CH685920A5 (fr) 1995-11-15
CA2135179A1 (en) 1993-11-11
AU4064093A (en) 1993-11-29
CZ283512B6 (cs) 1998-04-15
DE69317418T2 (de) 1998-07-30
HUT71418A (en) 1995-11-28
KR100253111B1 (en) 2000-07-01
AU670083B2 (en) 1996-07-04
HU211638A9 (en) 1995-12-28
US5705506A (en) 1998-01-06
FR2690847B1 (fr) 1995-06-09
CZ272394A3 (en) 1995-10-18
NO306700B1 (no) 1999-12-13
NO944214L (no) 1994-11-07
ATE163850T1 (de) 1998-03-15
EP0639072A1 (en) 1995-02-22
BG99167A (bg) 1995-06-30
SG46649A1 (en) 1998-02-20
NZ252132A (en) 1996-09-25
ITRM930286A1 (it) 1994-11-06
GB2266665B (en) 1996-05-22
UA37206C2 (uk) 2001-05-15
GB9309209D0 (en) 1993-06-16
BG62120B1 (bg) 1999-03-31
IE930339A1 (en) 1993-11-17
IE75203B1 (en) 1997-08-27
IL105468A0 (en) 1993-08-18
RO112993B1 (ro) 1998-03-30
RU2118527C1 (ru) 1998-09-10
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
TW231970B (OSRAM) 1994-10-11
BE1007024A5 (fr) 1995-02-21
ZA933178B (en) 1994-01-10
FR2690847A1 (fr) 1993-11-12
HU227338B1 (en) 2011-04-28
CA2135179C (en) 2000-12-05
BR1100108A (pt) 1999-12-07
NO944214D0 (no) 1994-11-04
IL105468A (en) 1998-09-24
CY2039B1 (en) 1998-04-30
JPH07506570A (ja) 1995-07-20
OA10109A (en) 1996-12-18
WO1993021916A1 (en) 1993-11-11
ES2113533T3 (es) 1998-05-01
HK95697A (en) 1997-08-08
IT1261471B (it) 1996-05-23

Similar Documents

Publication Publication Date Title
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
KR100253111B1 (en) Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
EP0903349A3 (en) CCR-3 receptor antagonists
DE69932173D1 (de) Adenine-derivate
MX9702865A (es) Agentes estrogenicos.
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
BG106142A (en) Glucocorticoid receptor modulators
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
IL114598A0 (en) Triazole compounds their preparation and pharmaceutical compositions containing them
NZ233784A (en) Pharmaceutical composition comprising an inclusion compound of imipramine or derivative in cyclodextrin
IL114600A0 (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical composition containing them
EP0485431A4 (en) Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
GR3036195T3 (en) Novel compounds
AU3524795A (en) Aromatic ethers derived from indols such as 5ht1-like ligands
BG102229A (en) Endothelium receptor antagonists
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
EP1051994A3 (en) 5HT1 receptor agonists and a COX-2 inhibitor for the treatment of migraine